Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 324 entries
Sorted by: Best Match Show Resources per page
MM Quadruply Bonded Complexes Supported by Vinylbenzoate Ligands: Synthesis, Characterization, Photophysical Properties and Application as Synthons.

Chemical science

Brown-Xu SE, Chisholm MH, Durr CB, Spilker TF, Young PJ.
PMID: 26417424
Chem Sci. 2015 Mar 01;6(3):1780-1791. doi: 10.1039/C4SC02542C. Epub 2015 Jan 13.

From the reactions between M

Cite
Brown-Xu SE, Chisholm MH, Durr CB, et al. MM Quadruply Bonded Complexes Supported by Vinylbenzoate Ligands: Synthesis, Characterization, Photophysical Properties and Application as Synthons. Chem Sci. 2015;6(3):1780-1791doi: 10.1039/C4SC02542C.
Brown-Xu, S. E., Chisholm, M. H., Durr, C. B., Spilker, T. F., & Young, P. J. (2015). MM Quadruply Bonded Complexes Supported by Vinylbenzoate Ligands: Synthesis, Characterization, Photophysical Properties and Application as Synthons. Chemical science, 6(3), 1780-1791. https://doi.org/10.1039/C4SC02542C
Brown-Xu, Samantha E, et al. "MM Quadruply Bonded Complexes Supported by Vinylbenzoate Ligands: Synthesis, Characterization, Photophysical Properties and Application as Synthons." Chemical science vol. 6,3 (2015): 1780-1791. doi: https://doi.org/10.1039/C4SC02542C
Brown-Xu SE, Chisholm MH, Durr CB, Spilker TF, Young PJ. MM Quadruply Bonded Complexes Supported by Vinylbenzoate Ligands: Synthesis, Characterization, Photophysical Properties and Application as Synthons. Chem Sci. 2015 Mar 01;6(3):1780-1791. doi: 10.1039/C4SC02542C. Epub 2015 Jan 13. PMID: 26417424; PMCID: PMC4583209.
Copy Download .nbib Format: NLM
TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma.

Oncotarget

Piao L, Mukherjee S, Chang Q, Xie X, Li H, Castellanos MR, Banerjee P, Iqbal H, Ivancic R, Wang X, Teknos TN, Pan Q.
PMID: 28947951
Oncotarget. 2016 Jul 16;8(36):60025-60035. doi: 10.18632/oncotarget.10620. eCollection 2017 Sep 01.

Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide with about 600,000 new cases diagnosed in the last year. The incidence of human papillomavirus-positive head and neck squamous cell carcinoma (HPV-positive HNSCC) has rapidly...

Cite
Piao L, Mukherjee S, Chang Q, et al. TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget. 2016;8(36):60025-60035doi: 10.18632/oncotarget.10620.
Piao, L., Mukherjee, S., Chang, Q., Xie, X., Li, H., Castellanos, M. R., Banerjee, P., Iqbal, H., Ivancic, R., Wang, X., Teknos, T. N., & Pan, Q. (2017). TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget, 8(36), 60025-60035. https://doi.org/10.18632/oncotarget.10620
Piao, Longzhu, et al. "TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma." Oncotarget vol. 8,36 (2017): 60025-60035. doi: https://doi.org/10.18632/oncotarget.10620
Piao L, Mukherjee S, Chang Q, Xie X, Li H, Castellanos MR, Banerjee P, Iqbal H, Ivancic R, Wang X, Teknos TN, Pan Q. TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget. 2016 Jul 16;8(36):60025-60035. doi: 10.18632/oncotarget.10620. eCollection 2017 Sep 01. PMID: 28947951; PMCID: PMC5601119.
Copy Download .nbib Format: NLM
Short-read, high-throughput sequencing technology for STR genotyping.

BioTechniques. Rapid dispatches

Bornman DM, Hester ME, Schuetter JM, Kasoji MD, Minard-Smith A, Barden CA, Nelson SC, Godbold GD, Baker CH, Yang B, Walther JE, Tornes IE, Yan PS, Rodriguez B, Bundschuh R, Dickens ML, Young BA, Faith SA.
PMID: 25621315
Biotech Rapid Dispatches. 2012 Apr;2012:1-6.

DNA-based methods for human identification principally rely upon genotyping of short tandem repeat (STR) loci. Electrophoretic-based techniques for variable-length classification of STRs are universally utilized, but are limited in that they have relatively low throughput and do not yield...

Cite
Bornman DM, Hester ME, Schuetter JM, et al. Short-read, high-throughput sequencing technology for STR genotyping. Biotech Rapid Dispatches. 2012;2012:1-6
Bornman, D. M., Hester, M. E., Schuetter, J. M., Kasoji, M. D., Minard-Smith, A., Barden, C. A., Nelson, S. C., Godbold, G. D., Baker, C. H., Yang, B., Walther, J. E., Tornes, I. E., Yan, P. S., Rodriguez, B., Bundschuh, R., Dickens, M. L., Young, B. A., & Faith, S. A. (2012). Short-read, high-throughput sequencing technology for STR genotyping. BioTechniques. Rapid dispatches, 20121-6.
Bornman, Daniel M, et al. "Short-read, high-throughput sequencing technology for STR genotyping." BioTechniques. Rapid dispatches vol. 2012 (2012): 1-6.
Bornman DM, Hester ME, Schuetter JM, Kasoji MD, Minard-Smith A, Barden CA, Nelson SC, Godbold GD, Baker CH, Yang B, Walther JE, Tornes IE, Yan PS, Rodriguez B, Bundschuh R, Dickens ML, Young BA, Faith SA. Short-read, high-throughput sequencing technology for STR genotyping. Biotech Rapid Dispatches. 2012 Apr;2012:1-6. PMID: 25621315; PMCID: PMC4301848.
Copy Download .nbib Format: NLM
Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis.

Clinical & experimental pharmacology

Zewdu A, Lopez G, Braggio D, Kenny C, Constantino D, Bid HK, Batte K, Iwenofu OH, Oberlies NH, Pearce CJ, Strohecker AM, Lev D, Pollock RE.
PMID: 28184331
Clin Exp Pharmacol. 2016 Nov;6(6). doi: 10.4172/2161-1459.1000221. Epub 2016 Oct 24.

OBJECTIVE: The heterogeneity of soft tissue sarcoma (STS) represents a major challenge for the development of effective therapeutics. Comprised of over 50 different histology subtypes of various etiologies, STS subsets are further characterized as either karyotypically simple or complex....

Cite
Zewdu A, Lopez G, Braggio D, et al. Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis. Clin Exp Pharmacol. 2016;6(6)doi: 10.4172/2161-1459.1000221.
Zewdu, A., Lopez, G., Braggio, D., Kenny, C., Constantino, D., Bid, H. K., Batte, K., Iwenofu, O. H., Oberlies, N. H., Pearce, C. J., Strohecker, A. M., Lev, D., & Pollock, R. E. (2016). Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis. Clinical & experimental pharmacology, 6(6), . https://doi.org/10.4172/2161-1459.1000221
Zewdu, A, et al. "Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis." Clinical & experimental pharmacology vol. 6,6 (2016). doi: https://doi.org/10.4172/2161-1459.1000221
Zewdu A, Lopez G, Braggio D, Kenny C, Constantino D, Bid HK, Batte K, Iwenofu OH, Oberlies NH, Pearce CJ, Strohecker AM, Lev D, Pollock RE. Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis. Clin Exp Pharmacol. 2016 Nov;6(6). doi: 10.4172/2161-1459.1000221. Epub 2016 Oct 24. PMID: 28184331; PMCID: PMC5295762.
Copy Download .nbib Format: NLM
Emotions and Emotion Regulation in Breast Cancer Survivorship.

Healthcare (Basel, Switzerland)

Conley CC, Bishop BT, Andersen BL.
PMID: 27517969
Healthcare (Basel). 2016 Aug 10;4(3). doi: 10.3390/healthcare4030056.

Emotional distress in cancer patients is an important outcome; however, emotional experience does not begin and end with emotion generation. Attempts to regulate emotions may lessen their potentially negative effects on physical and psychological well-being. Researchers have called for...

Cite
Conley CC, Bishop BT, Andersen BL. Emotions and Emotion Regulation in Breast Cancer Survivorship. Healthcare (Basel). 2016;4(3)doi: 10.3390/healthcare4030056.
Conley, C. C., Bishop, B. T., & Andersen, B. L. (2016). Emotions and Emotion Regulation in Breast Cancer Survivorship. Healthcare (Basel, Switzerland), 4(3), . https://doi.org/10.3390/healthcare4030056
Conley, Claire C, et al. "Emotions and Emotion Regulation in Breast Cancer Survivorship." Healthcare (Basel, Switzerland) vol. 4,3 (2016). doi: https://doi.org/10.3390/healthcare4030056
Conley CC, Bishop BT, Andersen BL. Emotions and Emotion Regulation in Breast Cancer Survivorship. Healthcare (Basel). 2016 Aug 10;4(3). doi: 10.3390/healthcare4030056. PMID: 27517969; PMCID: PMC5041057.
Copy Download .nbib Format: NLM
Revisiting the linkage between ethnomedical use and development of new medicines: A novel plant collection strategy towards the discovery of anticancer agents.

Journal of medicinal plant research

Henkin JM, Sydara K, Xayvue M, Souliya O, Kinghorn AD, Burdette JE, Chen WL, Elkington BG, Soejarto DD.
PMID: 29152156
J Med Plant Res. 2017 Oct;11(40):621-634. doi: 10.5897/jmpr2017.6485. Epub 2017 Oct 25.

The Vietnam-Laos International Cooperative Biodiversity Group (ICBG) based at the University of Illinois at Chicago (UIC) catalyzed a country-wide network of medicinal plant preserves (MPP) and medicinal biodiversity preserves (MBP) now established in ten provinces of the Lao People's...

Cite
Henkin JM, Sydara K, Xayvue M, et al. Revisiting the linkage between ethnomedical use and development of new medicines: A novel plant collection strategy towards the discovery of anticancer agents. J Med Plant Res. 2017;11(40):621-634doi: 10.5897/jmpr2017.6485.
Henkin, J. M., Sydara, K., Xayvue, M., Souliya, O., Kinghorn, A. D., Burdette, J. E., Chen, W. L., Elkington, B. G., & Soejarto, D. D. (2017). Revisiting the linkage between ethnomedical use and development of new medicines: A novel plant collection strategy towards the discovery of anticancer agents. Journal of medicinal plant research, 11(40), 621-634. https://doi.org/10.5897/jmpr2017.6485
Henkin, Joshua M, et al. "Revisiting the linkage between ethnomedical use and development of new medicines: A novel plant collection strategy towards the discovery of anticancer agents." Journal of medicinal plant research vol. 11,40 (2017): 621-634. doi: https://doi.org/10.5897/jmpr2017.6485
Henkin JM, Sydara K, Xayvue M, Souliya O, Kinghorn AD, Burdette JE, Chen WL, Elkington BG, Soejarto DD. Revisiting the linkage between ethnomedical use and development of new medicines: A novel plant collection strategy towards the discovery of anticancer agents. J Med Plant Res. 2017 Oct;11(40):621-634. doi: 10.5897/jmpr2017.6485. Epub 2017 Oct 25. PMID: 29152156; PMCID: PMC5686776.
Copy Download .nbib Format: NLM
Favorable effects of low-fat and low-carbohydrate dietary patterns on serum leptin, but not adiponectin, among overweight and obese premenopausal women: a randomized trial.

SpringerPlus

Llanos AA, Krok JL, Peng J, Pennell ML, Olivo-Marston S, Vitolins MZ, Degraffinreid CR, Paskett ED.
PMID: 24790820
Springerplus. 2014 Apr 04;3:175. doi: 10.1186/2193-1801-3-175. eCollection 2014.

CLINICAL TRIAL REGISTRATION NUMBER: NCT01559194.

Cite
Llanos AA, Krok JL, Peng J, et al. Favorable effects of low-fat and low-carbohydrate dietary patterns on serum leptin, but not adiponectin, among overweight and obese premenopausal women: a randomized trial. Springerplus. 2014;3:175doi: 10.1186/2193-1801-3-175.
Llanos, A. A., Krok, J. L., Peng, J., Pennell, M. L., Olivo-Marston, S., Vitolins, M. Z., Degraffinreid, C. R., & Paskett, E. D. (2014). Favorable effects of low-fat and low-carbohydrate dietary patterns on serum leptin, but not adiponectin, among overweight and obese premenopausal women: a randomized trial. SpringerPlus, 3175. https://doi.org/10.1186/2193-1801-3-175
Llanos, Adana Am, et al. "Favorable effects of low-fat and low-carbohydrate dietary patterns on serum leptin, but not adiponectin, among overweight and obese premenopausal women: a randomized trial." SpringerPlus vol. 3 (2014): 175. doi: https://doi.org/10.1186/2193-1801-3-175
Llanos AA, Krok JL, Peng J, Pennell ML, Olivo-Marston S, Vitolins MZ, Degraffinreid CR, Paskett ED. Favorable effects of low-fat and low-carbohydrate dietary patterns on serum leptin, but not adiponectin, among overweight and obese premenopausal women: a randomized trial. Springerplus. 2014 Apr 04;3:175. doi: 10.1186/2193-1801-3-175. eCollection 2014. PMID: 24790820; PMCID: PMC4000357.
Copy Download .nbib Format: NLM
The making of a miscreant: tobacco smoke and the creation of pathogen-rich biofilms.

NPJ biofilms and microbiomes

Shah SA, Ganesan SM, Varadharaj S, Dabdoub SM, Walters JD, Kumar PS.
PMID: 29081982
NPJ Biofilms Microbiomes. 2017 Oct 24;3:26. doi: 10.1038/s41522-017-0033-2. eCollection 2017.

We have previously reported that oral biofilms in clinically healthy smokers are pathogen-rich, and that this enrichment occurs within 24 h of biofilm formation. The present investigation aimed to identify a mechanism by which smoking creates this altered community...

Cite
Shah SA, Ganesan SM, Varadharaj S, et al. The making of a miscreant: tobacco smoke and the creation of pathogen-rich biofilms. NPJ Biofilms Microbiomes. 2017;3:26doi: 10.1038/s41522-017-0033-2.
Shah, S. A., Ganesan, S. M., Varadharaj, S., Dabdoub, S. M., Walters, J. D., & Kumar, P. S. (2017). The making of a miscreant: tobacco smoke and the creation of pathogen-rich biofilms. NPJ biofilms and microbiomes, 326. https://doi.org/10.1038/s41522-017-0033-2
Shah, Samir A, et al. "The making of a miscreant: tobacco smoke and the creation of pathogen-rich biofilms." NPJ biofilms and microbiomes vol. 3 (2017): 26. doi: https://doi.org/10.1038/s41522-017-0033-2
Shah SA, Ganesan SM, Varadharaj S, Dabdoub SM, Walters JD, Kumar PS. The making of a miscreant: tobacco smoke and the creation of pathogen-rich biofilms. NPJ Biofilms Microbiomes. 2017 Oct 24;3:26. doi: 10.1038/s41522-017-0033-2. eCollection 2017. PMID: 29081982; PMCID: PMC5655325.
Copy Download .nbib Format: NLM
Regulation of BLM Nucleolar Localization.

Genes

Tangeman L, McIlhatton MA, Grierson P, Groden J, Acharya S.
PMID: 27657136
Genes (Basel). 2016 Sep 21;7(9). doi: 10.3390/genes7090069.

Defects in coordinated ribosomal RNA (rRNA) transcription in the nucleolus cause cellular and organismal growth deficiencies. Bloom's syndrome, an autosomal recessive human disorder caused by mutated recQ-like helicase BLM, presents with growth defects suggestive of underlying defects in rRNA...

Cite
Tangeman L, McIlhatton MA, Grierson P, et al. Regulation of BLM Nucleolar Localization. Genes (Basel). 2016;7(9)doi: 10.3390/genes7090069.
Tangeman, L., McIlhatton, M. A., Grierson, P., Groden, J., & Acharya, S. (2016). Regulation of BLM Nucleolar Localization. Genes, 7(9), . https://doi.org/10.3390/genes7090069
Tangeman, Larissa, et al. "Regulation of BLM Nucleolar Localization." Genes vol. 7,9 (2016). doi: https://doi.org/10.3390/genes7090069
Tangeman L, McIlhatton MA, Grierson P, Groden J, Acharya S. Regulation of BLM Nucleolar Localization. Genes (Basel). 2016 Sep 21;7(9). doi: 10.3390/genes7090069. PMID: 27657136; PMCID: PMC5042399.
Copy Download .nbib Format: NLM
Expression of the fibroblast growth factor 4 (FGF-4) gene is regulated by serum in Tera-2 embryonal carcinoma cells.

International journal of oncology

Lucas J, Knobloch T, Lang J.
PMID: 21544372
Int J Oncol. 1996 Feb;8(2):377-81. doi: 10.3892/ijo.8.2.377.

Expression of the fibroblast growth factor 4 (FGF-4) gene is tightly regulated during mammalian development. Dysregulation of FGF-4 gene expression results in cell transformation and tumorigenesis. It is therefore pertinent to investigate the regulatory mechanisms which control expression of...

Cite
Lucas J, Knobloch T, Lang J. Expression of the fibroblast growth factor 4 (FGF-4) gene is regulated by serum in Tera-2 embryonal carcinoma cells. Int J Oncol. 1996;8(2):377-81doi: 10.3892/ijo.8.2.377.
Lucas, J., Knobloch, T., & Lang, J. (1996). Expression of the fibroblast growth factor 4 (FGF-4) gene is regulated by serum in Tera-2 embryonal carcinoma cells. International journal of oncology, 8(2), 377-81. https://doi.org/10.3892/ijo.8.2.377
Lucas, J, et al. "Expression of the fibroblast growth factor 4 (FGF-4) gene is regulated by serum in Tera-2 embryonal carcinoma cells." International journal of oncology vol. 8,2 (1996): 377-81. doi: https://doi.org/10.3892/ijo.8.2.377
Lucas J, Knobloch T, Lang J. Expression of the fibroblast growth factor 4 (FGF-4) gene is regulated by serum in Tera-2 embryonal carcinoma cells. Int J Oncol. 1996 Feb;8(2):377-81. doi: 10.3892/ijo.8.2.377. PMID: 21544372.
Copy Download .nbib Format: NLM
Differential downregulation of e-cadherin and desmoglein by epidermal growth factor.

Dermatology research and practice

Chavez MG, Buhr CA, Petrie WK, Wandinger-Ness A, Kusewitt DF, Hudson LG.
PMID: 22312325
Dermatol Res Pract. 2012;2012:309587. doi: 10.1155/2012/309587. Epub 2012 Jan 16.

Modulation of cell : cell junctions is a key event in cutaneous wound repair. In this study we report that activation of the epidermal growth factor (EGF) receptor disrupts cell : cell adhesion, but with different kinetics and fates...

Cite
Chavez MG, Buhr CA, Petrie WK, et al. Differential downregulation of e-cadherin and desmoglein by epidermal growth factor. Dermatol Res Pract. 2012;2012:309587doi: 10.1155/2012/309587.
Chavez, M. G., Buhr, C. A., Petrie, W. K., Wandinger-Ness, A., Kusewitt, D. F., & Hudson, L. G. (2012). Differential downregulation of e-cadherin and desmoglein by epidermal growth factor. Dermatology research and practice, 2012309587. https://doi.org/10.1155/2012/309587
Chavez, Miquella G, et al. "Differential downregulation of e-cadherin and desmoglein by epidermal growth factor." Dermatology research and practice vol. 2012 (2012): 309587. doi: https://doi.org/10.1155/2012/309587
Chavez MG, Buhr CA, Petrie WK, Wandinger-Ness A, Kusewitt DF, Hudson LG. Differential downregulation of e-cadherin and desmoglein by epidermal growth factor. Dermatol Res Pract. 2012;2012:309587. doi: 10.1155/2012/309587. Epub 2012 Jan 16. PMID: 22312325; PMCID: PMC3270554.
Copy Download .nbib Format: NLM
Simultaneous, single particle, magnetization and size measurements of micron sized, magnetic particles.

Journal of magnetism and magnetic materials

Xu J, Mahajan K, Xue W, Winter JO, Zborowski M, Chalmers JJ.
PMID: 22962515
J Magn Magn Mater. 2012 Dec 01;324(24):4189-4199. doi: 10.1016/j.jmmm.2012.07.039.

Single particle magnetization and size measurements of micron and nano sized, magnetic particles were made using a previously described device referred to as Cell Tracking Velocimetry, CTV. Three types of commercially available, and commonly used, magnetic particles were studied...

Cite
Xu J, Mahajan K, Xue W, et al. Simultaneous, single particle, magnetization and size measurements of micron sized, magnetic particles. J Magn Magn Mater. 2012;324(24):4189-4199doi: 10.1016/j.jmmm.2012.07.039.
Xu, J., Mahajan, K., Xue, W., Winter, J. O., Zborowski, M., & Chalmers, J. J. (2012). Simultaneous, single particle, magnetization and size measurements of micron sized, magnetic particles. Journal of magnetism and magnetic materials, 324(24), 4189-4199. https://doi.org/10.1016/j.jmmm.2012.07.039
Xu, Jie, et al. "Simultaneous, single particle, magnetization and size measurements of micron sized, magnetic particles." Journal of magnetism and magnetic materials vol. 324,24 (2012): 4189-4199. doi: https://doi.org/10.1016/j.jmmm.2012.07.039
Xu J, Mahajan K, Xue W, Winter JO, Zborowski M, Chalmers JJ. Simultaneous, single particle, magnetization and size measurements of micron sized, magnetic particles. J Magn Magn Mater. 2012 Dec 01;324(24):4189-4199. doi: 10.1016/j.jmmm.2012.07.039. PMID: 22962515; PMCID: PMC3433070.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 324 entries